Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
XWELL Inc
XWEL
Consumer Cyclical
Personal Services
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio...
-surveillance program. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:XWEL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 10:45am
XWELL, Inc. (NASDAQ:XWEL): Navigating Turbulence, Charting a
https://beyondspx.com/2024/08/02/xwell-inc-nasdaqxwel-navigating-turbulence-charting-a-path-to-profitability/
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 13, 2023 3:23am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Jul 15, 2022 9:05pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Jun 03, 2022 4:42am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Jun 02, 2022 12:00am
FSD Pharma Files Investigational New Drug Application “IND”
(2)
•••
Alfonsou
X
Post by
Alfonsou
on May 11, 2022 12:27am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 30, 2022 2:55am
Lucid-MS for Multiple Sclerosis Treatment
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 22, 2022 12:20am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 15, 2022 9:04am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 09, 2022 1:36am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 07, 2022 11:53am
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Apr 06, 2022 1:10am
iMining: First Hospital Foundation in Decentraland Metaverse
iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc
...more
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Feb 19, 2022 1:15am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(2)
•••
Alfonsou
X
Post by
Alfonsou
on Feb 04, 2022 10:19am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
(2)
•••
theNorm
X
Post by
theNorm
on Jan 14, 2022 6:52pm
Feb 3/21 when I last posted sp $2.10
Feb 14/21 it closed at $2.83 so you had to be quick and sell b4 it dropped to go onto a wild ride since. Time to think about buying this one again. Omicron discount right now
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages